Northern Trust’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$90.5K Sell
132,573
-64,056
-33% -$43.7K ﹤0.01% 4133
2025
Q1
$179K Sell
196,629
-11,577
-6% -$10.5K ﹤0.01% 3976
2024
Q4
$227K Buy
208,206
+69,892
+51% +$76.2K ﹤0.01% 3948
2024
Q3
$105K Sell
138,314
-212,105
-61% -$161K ﹤0.01% 4035
2024
Q2
$435K Sell
350,419
-14,763
-4% -$18.3K ﹤0.01% 3554
2024
Q1
$690K Sell
365,182
-16,185
-4% -$30.6K ﹤0.01% 3454
2023
Q4
$1.01M Buy
381,367
+52,682
+16% +$139K ﹤0.01% 3313
2023
Q3
$756K Sell
328,685
-2,750
-0.8% -$6.33K ﹤0.01% 3382
2023
Q2
$1.21M Buy
331,435
+253,135
+323% +$924K ﹤0.01% 3284
2023
Q1
$280K Buy
78,300
+15,711
+25% +$56.1K ﹤0.01% 3706
2022
Q4
$178K Hold
62,589
﹤0.01% 3917
2022
Q3
$139K Buy
62,589
+2,115
+3% +$4.7K ﹤0.01% 4012
2022
Q2
$150K Sell
60,474
-243,872
-80% -$605K ﹤0.01% 4026
2022
Q1
$1.49M Sell
304,346
-12,121
-4% -$59.2K ﹤0.01% 3246
2021
Q4
$3.58M Buy
316,467
+6,697
+2% +$75.7K ﹤0.01% 2900
2021
Q3
$4.51M Sell
309,770
-9,545
-3% -$139K ﹤0.01% 2790
2021
Q2
$3.72M Sell
319,315
-11,379
-3% -$133K ﹤0.01% 3014
2021
Q1
$4.04M Sell
330,694
-13,051
-4% -$159K ﹤0.01% 2878
2020
Q4
$4.3M Sell
343,745
-3,787
-1% -$47.4K ﹤0.01% 2769
2020
Q3
$5.23M Sell
347,532
-3,686
-1% -$55.5K ﹤0.01% 2505
2020
Q2
$8.61M Buy
351,218
+114,744
+49% +$2.81M ﹤0.01% 2192
2020
Q1
$3.36M Buy
236,474
+16,401
+7% +$233K ﹤0.01% 2539
2019
Q4
$3.49M Sell
220,073
-3,579
-2% -$56.8K ﹤0.01% 2798
2019
Q3
$1.89M Buy
223,652
+19,097
+9% +$161K ﹤0.01% 3136
2019
Q2
$1.84M Buy
204,555
+3,970
+2% +$35.7K ﹤0.01% 3120
2019
Q1
$1.55M Buy
200,585
+11,013
+6% +$85.2K ﹤0.01% 3210
2018
Q4
$891K Sell
189,572
-1,401
-0.7% -$6.59K ﹤0.01% 3400
2018
Q3
$1.73M Buy
190,973
+10,487
+6% +$94.9K ﹤0.01% 3281
2018
Q2
$2.14M Buy
180,486
+105,333
+140% +$1.25M ﹤0.01% 3177
2018
Q1
$1.06M Buy
+75,153
New +$1.06M ﹤0.01% 3363